Assessing risk of breast cancer recurrence

US12100146B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12100146-B2
Application numberUS-202217685115-A
CountryUS
Kind codeB2
Filing dateMar 2, 2022
Priority dateJun 10, 2014
Publication dateSep 24, 2024
Grant dateSep 24, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The subject disclosure presents systems and computer-implemented methods for assessing a risk of cancer recurrence in a patient based on a holistic integration of large amounts of prognostic information for said patient into a single comparative prognostic dataset. A risk classification system may be trained using the large amounts of information from a cohort of training slides from several patients, along with survival data for said patients. For example, a machine-learning-based binary classifier in the risk classification system may be trained using a set of granular image features computed from a plurality of slides corresponding to several cancer patients whose survival information is known and input into the system. The trained classifier may be used to classify image features from one or more test patients into a low-risk or high-risk group.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method comprising: accessing a first image depicting at least part of a training tissue sample stained with a first type of stain; accessing a second image depicting at least part of the training tissue sample stained with a second type of stain; identifying, for the first image, a first plurality of marker-specific features; identifying, for the second image, a second plurality of marker-specific features, wherein each marker-specific feature of the first or second plurality of marker-specific features includes a value that identifies one or more characteristics of a biological feature of the training tissue sample; applying a machine-learning model to one or more marker-specific features of the first plurality of marker-specific features and one or more marker-specific features of the second plurality of marker-specific features to determine a set of prognostic marker-specific features of the training tissue sample; computing a plurality of inter-marker features of the first and second images, wherein each inter-marker feature of the plurality of inter-marker features is computed based on a first marker-specific feature of the first plurality of marker-specific features and a second marker-specific feature of the second plurality of marker-specific features; applying the machine-learning model to one or more inter-marker features of the plurality of inter-marker features to determine a set of prognostic inter-marker features of the training tissue sample; training a breast-cancer recurrence model using the set of prognostic marker-specific features and the set of prognostic inter-marker features, wherein the breast-cancer recurrence model is trained to process another image to predict a breast-cancer recurrence risk level for a particular subject; and outputting the trained breast-cancer recurrence model. 2. The method of claim 1 , wherein the set of prognostic inter-marker features and/or the set of prognostic marker-specific features are determined further based on applying the machine-learning model to survival data, wherein the survival data include breast-cancer recurrence data of a subject from which the training tissue sample has been obtained. 3. The method of claim 1 , wherein the machine-learning model includes an L1-regularized logistic regression algorithm. 4. The method of claim 1 , wherein the first plurality of marker-specific features include a nucleus blob shape feature, a nucleus blob area feature, a nucleus blob compactness feature, a nucleus blob density feature, a normalized color feature, an absolute color feature, a center vote strength, an annular region based feature, or a blob topography feature. 5. The method of claim 1 , wherein the first type of stain includes a hematoxylin-and-eosin (H&E) stain. 6. The method of claim 1 , wherein the second type of stain includes a multiplex immunohistochemical (IHC) stain. 7. The method of claim 1 , wherein: a first number of the first plurality of marker-specific features is less than 500; and a second number of the set of prognostic marker-specific features is less than 50, wherein the second number is less than the first number. 8. The method of claim 1 , wherein a number of the plurality of inter-marker features is greater than 500. 9. The method of claim 8 , wherein the number of the plurality of inter-marker features is less than 2000. 10. A system comprising: one or more processors; and a memory coupled to the processor, the memory storing computer readable instructions that, when executed by the processor, cause the one or more processors to perform operations comprising: accessing a first image depicting at least part of a training tissue sample stained with a first type of stain; accessing a second image depicting at least part of the training tissue sample stained with a second type of stain; identifying, for the first image, a first plurality of marker-specific features; identifying, for the second image, a second plurality of marker-specific features, wherein each marker-specific feature of the first or second plurality of marker-specific features includes a value that identifies one or more characteristics of a biological feature of the training tissue sample; applying a machine-learning model to one or more marker-specific features of the first plurality of marker-specific features and one or more marker-specific features of the second plurality of marker-specific features to determine a set of prognostic marker-specific features of the training tissue sample; computing a plurality of inter-marker features of the first and second images, wherein each inter-marker feature of the plurality of inter-marker features is computed based on a first marker-specific feature of the first plurality of marker-specific features and a second marker-specific feature of the second plurality of marker-specific features; applying the machine-learning model to one or more inter-marker features of the plurality of inter-marker features to determine a set of prognostic inter-marker features of the training tissue sample; training a breast-cancer recurrence model using the set of prognostic marker-specific features and the set of prognostic inter-marker features, wherein the breast-cancer recurrence model is trained to process another image to predict a breast-cancer recurrence risk level for a particular subject; and outputting the trained breast-cancer recurrence model. 11. The system of claim 10 , wherein the set of prognostic inter-marker features and/or the set of prognostic marker-specific features are determined further based on applying the machine-learning model to survival data, wherein the survival data include breast-cancer recurrence data of a subject from which the training tissue sample has been obtained. 12. The system of claim 10 , wherein the machine-learning model includes an L1-regularized logistic regression algorithm. 13. The system of claim 10 , wherein the first plurality of marker-specific features include a nucleus blob shape feature, a nucleus blob area feature, a nucleus blob compactness feature, a nucleus blob density feature, a normalized color feature, an absolute color feature, a center vote strength, an annular region based feature, or a blob topography feature. 14. The system of claim 10 , wherein the first type of stain includes a hematoxylin-and-eosin (H&E) stain. 15. The system of claim 10 , wherein the second type of stain includes a multiplex immunohistochemical (IHC) stain. 16. A computer program product tangibly embodied in a non-transitory machine-readable storage medium, including instructions configured to cause one or more data processors to perform operations comprising: accessing a first image depicting at least part of a training tissue sample stained with a first type of stain; accessing a second image depicting at least part of the training tissue sample stained with a second type of stain; identifying, for the first image, a first plurality of marker-specific features; identifying, for the second image, a second plurality of marker-specific features, wherein each marker-specific feature of the first or second plurality of marker-specific features includes a value that identifies one or more characteristics of a biological feature of the training tissue sample; applying a machine-learning model to one or more marker-specific features of the first plurality of marker-specific features and one or more marker-specific features of the second plurality of marker-specific features to determine a set of prognostic marker-specific features of

Assignees

Inventors

Classifications

  • of extracted features · CPC title

  • Feature selection, e.g. selecting representative features from a multi-dimensional feature space · CPC title

  • of extracted features · CPC title

  • Selection of the most significant subset of features · CPC title

  • Matching; Classification · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12100146B2 cover?
The subject disclosure presents systems and computer-implemented methods for assessing a risk of cancer recurrence in a patient based on a holistic integration of large amounts of prognostic information for said patient into a single comparative prognostic dataset. A risk classification system may be trained using the large amounts of information from a cohort of training slides from several pa…
Who is the assignee on this patent?
Ventana Med Syst Inc, Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification G06T7/0012. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).